In line with the result of Decressac et al. [15], we observed significantly reduced nuclear TFEB immunoreactivity in SNpc dopaminergic neurons and an overall reduction of CLEAR genes expression levels in the midbrain of patients with sPD/DLB and, particularly, with GBA-PD/DLB. The gene discussed is TFEB; the disease is Parkinson disease.